HEADER HYDROLASE 14-NOV-03 1RHJ
TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE
TITLE 2 INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CASPASE-3;
COMPND 3 CHAIN: A, C;
COMPND 4 FRAGMENT: P17 SUBUNIT;
COMPND 5 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN,
COMPND 6 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1;
COMPND 7 EC: 3.4.22.-;
COMPND 8 ENGINEERED: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: CASPASE-3;
COMPND 11 CHAIN: B, D;
COMPND 12 FRAGMENT: P12 SUBUNIT;
COMPND 13 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN,
COMPND 14 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1;
COMPND 15 EC: 3.4.22.-;
COMPND 16 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: CASP3, CPP32;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET20B+;
SOURCE 11 MOL_ID: 2;
SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 13 ORGANISM_COMMON: HUMAN;
SOURCE 14 ORGANISM_TAXID: 9606;
SOURCE 15 GENE: CASP3, CPP32;
SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID
KEYWDS CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, COMPLEX
KEYWDS 2 (PROTEASE-INHIBITOR), HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR J.W.BECKER,J.ROTONDA,S.M.SOISSON
REVDAT 6 30-OCT-24 1RHJ 1 REMARK
REVDAT 5 20-SEP-23 1RHJ 1 REMARK
REVDAT 4 21-DEC-22 1RHJ 1 REMARK SEQADV LINK
REVDAT 3 11-OCT-17 1RHJ 1 REMARK
REVDAT 2 24-FEB-09 1RHJ 1 VERSN
REVDAT 1 11-MAY-04 1RHJ 0
JRNL AUTH J.W.BECKER,J.ROTONDA,S.M.SOISSON,R.ASPIOTIS,C.BAYLY,
JRNL AUTH 2 S.FRANCOEUR,M.GALLANT,M.GARCIA-CALVO,A.GIROUX,E.GRIMM,Y.HAN,
JRNL AUTH 3 D.MCKAY,D.W.NICHOLSON,E.PETERSON,J.RENAUD,S.ROY,
JRNL AUTH 4 N.THORNBERRY,R.ZAMBONI
JRNL TITL REDUCING THE PEPTIDYL FEATURES OF CASPASE-3 INHIBITORS: A
JRNL TITL 2 STRUCTURAL ANALYSIS.
JRNL REF J.MED.CHEM. V. 47 2466 2004
JRNL REFN ISSN 0022-2623
JRNL PMID 15115390
JRNL DOI 10.1021/JM0305523
REMARK 2
REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2002
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 175071.300
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.1
REMARK 3 NUMBER OF REFLECTIONS : 29784
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.204
REMARK 3 R VALUE (WORKING SET) : 0.204
REMARK 3 FREE R VALUE : 0.252
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000
REMARK 3 FREE R VALUE TEST SET COUNT : 2987
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 29784
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.00
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4086
REMARK 3 BIN R VALUE (WORKING SET) : 0.2250
REMARK 3 BIN FREE R VALUE : 0.2850
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 469
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3740
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 82
REMARK 3 SOLVENT ATOMS : 233
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 10.60
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.10
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.58000
REMARK 3 B22 (A**2) : 3.84000
REMARK 3 B33 (A**2) : -4.42000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -3.76000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25
REMARK 3 ESD FROM SIGMAA (A) : 0.18
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.006
REMARK 3 BOND ANGLES (DEGREES) : 1.300
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.320 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.070 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.220 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.200 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.37
REMARK 3 BSOL : 40.66
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P
REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : PYR.PAR
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : ION.TOP
REMARK 3 TOPOLOGY FILE 4 : PYR.TOP
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK 4
REMARK 4 1RHJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-NOV-03.
REMARK 100 THE DEPOSITION ID IS D_1000020749.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-SEP-00
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 4.8
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30288
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 19.900
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6
REMARK 200 DATA REDUNDANCY : 3.360
REMARK 200 R MERGE (I) : 0.05600
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28
REMARK 200 COMPLETENESS FOR SHELL (%) : 76.6
REMARK 200 DATA REDUNDANCY IN SHELL : 3.41
REMARK 200 R MERGE FOR SHELL (I) : 0.16400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNX
REMARK 200 STARTING MODEL: PROTEIN PART OF 1PAU.PDB
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.66
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG-6000, 100 MM CITRATE, 20 MM L
REMARK 280 -CYSTEINE, 5 MM GLYCEROL, 3 MM NAN(3), PH 4.8, VAPOR DIFFUSION,
REMARK 280 HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.38200
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 15170 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 17050 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -71.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER A 145
REMARK 465 GLY A 146
REMARK 465 ILE A 147
REMARK 465 SER A 148
REMARK 465 LEU A 149
REMARK 465 THR A 296
REMARK 465 ASP A 297
REMARK 465 SER B 310
REMARK 465 GLY B 311
REMARK 465 VAL B 312
REMARK 465 ASP B 313
REMARK 465 ASP B 314
REMARK 465 ASP B 315
REMARK 465 MET B 316
REMARK 465 ALA B 317
REMARK 465 CYS B 318
REMARK 465 HIS B 319
REMARK 465 HIS B 402
REMARK 465 LEU B 403
REMARK 465 GLU B 404
REMARK 465 HIS B 405
REMARK 465 HIS B 406
REMARK 465 HIS B 407
REMARK 465 HIS B 408
REMARK 465 HIS B 409
REMARK 465 HIS B 410
REMARK 465 SER C 645
REMARK 465 GLY C 646
REMARK 465 ILE C 647
REMARK 465 SER C 648
REMARK 465 LEU C 649
REMARK 465 THR C 796
REMARK 465 ASP C 797
REMARK 465 SER D 810
REMARK 465 GLY D 811
REMARK 465 VAL D 812
REMARK 465 ASP D 813
REMARK 465 ASP D 814
REMARK 465 ASP D 815
REMARK 465 MET D 816
REMARK 465 ALA D 817
REMARK 465 CYS D 818
REMARK 465 HIS D 819
REMARK 465 HIS D 902
REMARK 465 LEU D 903
REMARK 465 GLU D 904
REMARK 465 HIS D 905
REMARK 465 HIS D 906
REMARK 465 HIS D 907
REMARK 465 HIS D 908
REMARK 465 HIS D 909
REMARK 465 HIS D 910
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 175A -1.66 -58.09
REMARK 500 LYS A 197 30.85 78.59
REMARK 500 ASP A 205 73.49 35.98
REMARK 500 SER A 236 -170.27 -175.07
REMARK 500 CYS A 270 79.46 -119.97
REMARK 500 LYS B 363 -58.21 -130.85
REMARK 500 PHE B 400 30.87 -84.23
REMARK 500 LYS C 697 32.34 72.22
REMARK 500 ASP C 705 75.67 42.63
REMARK 500 SER C 736 -170.78 -178.38
REMARK 500 ASP D 826 32.98 74.27
REMARK 500 LYS D 863 -46.64 -145.08
REMARK 500 PHE D 900 30.07 -84.79
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZN C 502
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZN A 501
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1PAU RELATED DB: PDB
REMARK 900 CASPASE-3 COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-ALDEHYDE
REMARK 900 RELATED ID: 1RHK RELATED DB: PDB
REMARK 900 RELATED ID: 1RHM RELATED DB: PDB
REMARK 900 RELATED ID: 1RHQ RELATED DB: PDB
REMARK 900 RELATED ID: 1RHR RELATED DB: PDB
REMARK 900 RELATED ID: 1RHU RELATED DB: PDB
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE HIS TAGS ON CHAINS B AND D WERE NOT
REMARK 999 CLEAVED FOR THIS ENTRY.
DBREF 1RHJ A 145 297 UNP P42574 CASP3_HUMAN 29 175
DBREF 1RHJ B 310 402 UNP P42574 CASP3_HUMAN 176 277
DBREF 1RHJ C 645 797 UNP P42574 CASP3_HUMAN 29 175
DBREF 1RHJ D 810 902 UNP P42574 CASP3_HUMAN 176 277
SEQADV 1RHJ GLU B 324 UNP P42574 ASP 190 VARIANT
SEQADV 1RHJ LEU B 403 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ GLU B 404 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS B 405 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS B 406 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS B 407 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS B 408 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS B 409 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS B 410 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ GLU D 824 UNP P42574 ASP 190 VARIANT
SEQADV 1RHJ LEU D 903 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ GLU D 904 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS D 905 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS D 906 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS D 907 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS D 908 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS D 909 UNP P42574 EXPRESSION TAG
SEQADV 1RHJ HIS D 910 UNP P42574 EXPRESSION TAG
SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR
SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN
SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR
SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN
SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG
SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU
SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU
SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY
SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY
SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE
SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY
SEQRES 12 A 147 ILE GLU THR ASP
SEQRES 1 B 110 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO
SEQRES 2 B 110 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO
SEQRES 3 B 110 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP
SEQRES 4 B 110 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA
SEQRES 5 B 110 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN
SEQRES 6 B 110 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP
SEQRES 7 B 110 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL
SEQRES 8 B 110 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS LEU GLU
SEQRES 9 B 110 HIS HIS HIS HIS HIS HIS
SEQRES 1 C 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR
SEQRES 2 C 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN
SEQRES 3 C 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR
SEQRES 4 C 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN
SEQRES 5 C 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG
SEQRES 6 C 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU
SEQRES 7 C 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU
SEQRES 8 C 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY
SEQRES 9 C 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY
SEQRES 10 C 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE
SEQRES 11 C 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY
SEQRES 12 C 147 ILE GLU THR ASP
SEQRES 1 D 110 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO
SEQRES 2 D 110 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO
SEQRES 3 D 110 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP
SEQRES 4 D 110 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA
SEQRES 5 D 110 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN
SEQRES 6 D 110 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP
SEQRES 7 D 110 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL
SEQRES 8 D 110 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS LEU GLU
SEQRES 9 D 110 HIS HIS HIS HIS HIS HIS
HET PZN A 501 41
HET PZN C 502 41
HETNAM PZN 3-(2-{5-TERT-BUTYL-3-[(4-METHYL-FURAZAN-3-YLMETHYL)-
HETNAM 2 PZN AMINO]-2-OXO-2H-PYRAZIN-1-YL}-BUTYRYLAMINO)-5-(HEXYL-
HETNAM 3 PZN METHYL-AMINO)-4-OXO-PENTANOIC ACID ANION
FORMUL 5 PZN 2(C28 H44 N7 O6 1-)
FORMUL 7 HOH *233(H2 O)
HELIX 1 1 HIS A 174 GLY A 175C 5 5
HELIX 2 2 GLY A 181 LEU A 196 1 16
HELIX 3 3 THR A 207 LYS A 220 1 14
HELIX 4 4 LEU A 258 PHE A 264 1 7
HELIX 5 5 CYS A 270 THR A 274 5 5
HELIX 6 6 TRP B 348 ALA B 361 1 14
HELIX 7 7 GLU B 365 PHE B 380 1 17
HELIX 8 8 ASP B 381E HIS B 381I 5 5
HELIX 9 9 HIS C 674 GLY C 675C 5 5
HELIX 10 10 GLY C 681 LEU C 696 1 16
HELIX 11 11 THR C 707 GLU C 721 1 15
HELIX 12 12 LEU C 758 PHE C 764 1 7
HELIX 13 13 CYS C 770 THR C 774 5 5
HELIX 14 14 TRP D 848 ALA D 861 1 14
HELIX 15 15 GLU D 865 PHE D 880 1 17
HELIX 16 16 ASP D 881E HIS D 881I 5 5
SHEET 1 A12 GLU A 199 ASN A 204 0
SHEET 2 A12 GLU A 162 ASN A 169 1 N ILE A 167 O ARG A 201
SHEET 3 A12 ARG A 227 LEU A 235 1 O VAL A 233 N ILE A 166
SHEET 4 A12 LYS A 278 GLN A 283 1 O LEU A 279 N PHE A 230
SHEET 5 A12 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280
SHEET 6 A12 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329
SHEET 7 A12 CYS D 888 MET D 893 -1 O SER D 892 N ILE B 389
SHEET 8 A12 PHE D 827 TYR D 831 -1 N TYR D 829 O VAL D 890
SHEET 9 A12 LYS C 778 GLN C 783 1 N PHE C 780 O LEU D 828
SHEET 10 A12 ARG C 727 LEU C 735 1 N PHE C 730 O LEU C 779
SHEET 11 A12 GLU C 662 ASN C 669 1 N ILE C 666 O VAL C 733
SHEET 12 A12 GLU C 699 ASN C 704 1 O LYS C 703 N ASN C 669
SHEET 1 B 3 GLY A 238 GLU A 239 0
SHEET 2 B 3 ILE A 242 GLY A 245 -1 O ILE A 242 N GLU A 239
SHEET 3 B 3 GLY A 254 ASP A 257 -1 O GLY A 254 N GLY A 245
SHEET 1 C 2 ARG B 341 ASN B 342 0
SHEET 2 C 2 GLY B 346 SER B 347 -1 O GLY B 346 N ASN B 342
SHEET 1 D 3 GLY C 738 GLU C 739 0
SHEET 2 D 3 ILE C 742 GLY C 745 -1 O ILE C 742 N GLU C 739
SHEET 3 D 3 GLY C 754 ASP C 757 -1 O GLY C 754 N GLY C 745
SHEET 1 E 2 ARG D 841 ASN D 842 0
SHEET 2 E 2 GLY D 846 SER D 847 -1 O GLY D 846 N ASN D 842
LINK SG CYS A 285 C9 PZN A 501 1555 1555 1.85
LINK C9 PZN C 502 SG CYS C 785 1555 1555 1.85
SITE 1 AC1 13 HOH C 190 ARG C 679 SER C 736 HIS C 737
SITE 2 AC1 13 GLY C 738 GLN C 783 CYS C 785 TYR D 838
SITE 3 AC1 13 SER D 839 TRP D 840 ARG D 841 SER D 881A
SITE 4 AC1 13 PHE D 881B
SITE 1 AC2 15 ARG A 179 HIS A 237 GLY A 238 GLN A 283
SITE 2 AC2 15 ALA A 284 CYS A 285 HOH A 519 HOH A 524
SITE 3 AC2 15 TYR B 338 SER B 339 TRP B 340 ARG B 341
SITE 4 AC2 15 SER B 381A PHE B 381B PHE B 381H
CRYST1 50.187 68.764 93.008 90.00 101.46 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019925 0.000000 0.004039 0.00000
SCALE2 0.000000 0.014542 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010970 0.00000